These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9598451)

  • 41. Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
    van den Broek IV; Maung UA; Peters A; Liem L; Kamal M; Rahman M; Rahman MR; Bangali AM; Das S; Barends M; Faiz AM
    Trans R Soc Trop Med Hyg; 2005 Oct; 99(10):727-35. PubMed ID: 16095643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria.
    Salako LA; Aderounmu AF; Laoye JO; Makinde JM; Adio RA
    Ann Trop Med Parasitol; 1988 Aug; 82(4):325-30. PubMed ID: 3075441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial.
    Priotto G; Kabakyenga J; Pinoges L; Ruiz A; Eriksson T; Coussement F; Ngambe T; Taylor WR; Perea W; Guthmann JP; Olliaro P; Legros D
    Trans R Soc Trop Med Hyg; 2003; 97(3):325-30. PubMed ID: 15228253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
    de Souza JM; Sheth UK; de Oliveira RM; Gomes AT; Cavalcante EQ
    Bull World Health Organ; 1985; 63(3):611-5. PubMed ID: 3899398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
    Capan-Melser M; Mombo Ngoma G; Akerey-Diop D; Basra A; Würbel H; Groger M; Mackanga JR; Zoleko-Manego R; Schipulle U; Schwing J; Lötsch F; Rehman K; Matsiegui PB; Agnandji ST; Adegnika AA; Bélard S; González R; Kremsner PG; Menendez C; Ramharter M
    J Antimicrob Chemother; 2015; 70(6):1898-902. PubMed ID: 25722300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
    Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
    Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
    Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
    Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized trial comparing the efficacy of four treatment regimens for uncomplicated falciparum malaria in Assam state, India.
    Campbell P; Baruah S; Narain K; Rogers CC
    Trans R Soc Trop Med Hyg; 2006 Feb; 100(2):108-18. PubMed ID: 16289651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of mefloquine in combination with sulfadoxine-pyrimethamine and primaquine in male Thai patients with falciparum malaria.
    Karbwang J; Back DJ; Bunnag D; Breckenridge AM
    Bull World Health Organ; 1990; 68(5):633-8. PubMed ID: 2289299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.
    Ekue JM; Simooya OO; Sheth UK; Wernsdorfer WH; Njelesani EK
    Bull World Health Organ; 1985; 63(2):339-43. PubMed ID: 3893778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan.
    Adam I; A-Elbasit IE; Idris SM; Malik EM; Elbashir MI
    Ann Trop Med Parasitol; 2005 Jul; 99(5):449-55. PubMed ID: 16004704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mefloquine sulfadoxine pyrimethamine (MSP) combination delays in vitro emergence of mefloquine resistance in multiple drug resistant Plasmodium falciparum.
    Brockelman CR; Thanomsub B; Bhisutthibhand J
    Southeast Asian J Trop Med Public Health; 1989 Sep; 20(3):371-8. PubMed ID: 2699083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic study of mefloquine in Thai children aged 5-12 years suffering from uncomplicated falciparum malaria treated with MSP or MSP plus primaquine.
    Singhasivanon V; Chongsuphajaisiddhi T; Sabchareon A; Attanath P; Webster HK; Edstein MD; Lika ID
    Eur J Drug Metab Pharmacokinet; 1994; 19(1):27-32. PubMed ID: 7957448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of mefloquine-sulfadoxine-pyrimethamine vs quinine on patients with complicated falciparum malaria.
    Myint PT; Shwe T
    Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):223-5. PubMed ID: 3313739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Responses of multidrug-resistant Plasmodium falciparum parasites to mefloquine in Nigerian children.
    Okoyeh JN; Lege-Oguntoye L; Ugbode RO; Ogunrinde GO
    Trop Med Int Health; 1997 Apr; 2(4):319-24. PubMed ID: 9171839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
    Tall A; Rabarijaona LP; Robert V; Bedja SA; Ariey F; Randrianarivelojosia M
    Acta Trop; 2007 Jun; 102(3):176-81. PubMed ID: 17568549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemosuppression of malaria by the triple combination mefloquine/sulfadoxine/pyrimethamine: a field trial in an endemic area in Malaysia.
    Navaratnam V; Mohamad M; Hussain S; Kumar A; Jamaludin A; Sulaiman I; Mahsufi S; Selliah K
    Trans R Soc Trop Med Hyg; 1989; 83(6):755-9. PubMed ID: 2694509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phase I clinical trial of mefloquine in Brazilian male subjects.
    de Souza JM
    Bull World Health Organ; 1983; 61(5):809-14. PubMed ID: 6360400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.